Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5896474 | Best Practice & Research Clinical Endocrinology & Metabolism | 2016 | 20 Pages |
Abstract
In the present review, we discuss advantages and disadvantages of GH replacement therapy in survivors of pediatric malignancies, taking into consideration the different reasons for treating GHD during childhood or adult life. It is doubtless that GH treatment is advisable to obtain a normal growth in pediatric patients. As far as the beginning/continuation of the replacement therapy in adult age is concerned, contrasting results have been reported in literature. The suggestion is that the decision to treat adult CCS should be taken after careful evaluation of each patient's clinical history and of the potential side effects, in agreement with the patients.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Francesco (Medical Endocrinologist), Nicoletta (Medical Endocrinologist), Emanuela (Full Professor of Endocrinology), Dr. (Medical Endocrinologist),